SCHEMBL12295474

SCHEMBL12295474

O=C(NC1CC1)c1cncc2sc(N3CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)[C@@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
EPHX2 P34913 2/20 0.38
MMP1 P03956 5/20 0.38
MMP9 P14780 5/20 0.38
MMP13 P45452 3/20 0.38
MMP3 P08254 4/20 0.38
MMP7 P09237 4/20 0.38
FKBP1A P62942 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4472062 0.92 EPHX2 (0.41) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL4492730 0.92 TRPA1 (0.39) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2443277 0.91 TRPA1 (0.42) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2443265 0.91 TRPA1 (0.42) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL4482914 0.91 TRPA1 (0.43) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2437195 0.87 MMP1 (0.40) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2437190 0.87 MMP1 (0.40) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2441269 0.86 TP53 (0.39) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2441268 0.86 TP53 (0.39) TRPA1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2443625 0.84 TRPA1 (0.42) TRPA1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017612-B2 therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors JAPAN TOBACCO INC. (JP) 2011-09-13 US disclosed
US-8017612-B2 therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors JAPAN TOBACCO INC. (JP) 2011-09-13 US disclosed